2008 ICD-9-CM Procedure 99.28
- Injection or infusion of biological response modifier [brm] as an antineoplastic agent
- 99.28 is a specific code that can be used to specify a procedure
- 99.28 contains 25 index entries
- View the full ICD-9-CM Volume 3 99.* hierarchy
99.28 also known as:- Immunotherapy, antineoplastic
- Infusion of cintredekin besudotox
- Interleukin therapy
- Low-dose interleukin-2 (IL-2) therapy
- Tumor vaccine
99.28 excludes: - high-dose infusion interleukin-2 [IL-2] (00.15)
Index entries containing 99.28:- Immunotherapy, antineoplastic
99.28- C-Parvum
99.28 - Interferon
99.28 - Interleukin-2 (low-dose)
99.28 - Levamisole
99.28 - Proleukin (low-dose)
99.28 - Thymosin
99.28 Infusion (intra-arterial) (intravenous)- antineoplastic agent (chemotherapeutic) 99.25
- biological response modifier [BRM]
99.28 - cintredekin besudotox
99.28 - low-dose interleukin-2
99.28
- biological response modifier [BRM], antineoplastic agent
99.28- cintredekin besudotox
99.28 - high-dose interleukin-2 00.15
- low-dose interleukin-2
99.28
- cintredekin besudotox
99.28 - Proleukin (low-dose)
99.28 - vaccine
- tumor
99.28
Injection (into) (hypodermically) (intramuscularly) (intravenously) (acting locally or systemically)- antineoplastic agent (chemotherapeutic) NEC 99.25
- biological response modifier [BRM]
99.28 - cintredekin besudotox
99.28 - low-dose interleukin-2
99.28
- biological response modifier [BRM], antineoplastic agent
99.28- cintredekin besudotox
99.28 - high-dose interleukin-2 00.15
- low-dose interleukin-2
99.28
- cintredekin besudotox
99.28 - vaccine
- tumor
99.28
Vaccination (prophylactic) (against) 99.59- tumor
99.28
|
|
|